ArticleFrontiers in medicine2026
Building novel LLM-enabled explainable ensemble transformer models combining endoscopic and CT images for discriminating the different grades of gastrointestinal cancers.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal cancer (GC) is particularly malignant as they tend to progress slowly before advanced stages due to the forecast of early-specific symptoms. The heterogeneous properties of GCs require extremely precise and sensitive diagnostic techniques that can integrate in-depth structural information and surface-level data to distinguish cancer severity grades, thereby significantly lowering mortality rates. Deep learning (DL) algorithms are crucial in the classification of these various GC grades. However, the algorithms cannot detect interpretability and are characterized by a high probability of false alarm rates in detecting the underlying acute relationship between the medical images. Additionally, existing systems lack language-level transparency, preventing them from generating user-based narrative diagnostic explanations consistent with medical standards. To address this aforementioned challenge, this research study introduces a novel explainable LLM (X-LLM) based DL framework, which overcomes the drawbacks of existing DL algorithms. The suggested framework uses the ensemble transformer architectures that combine the clinical features by integrating the endoscopy and computer tomography (CT) scan images for enhancing the performance in detecting the different severity grades of GCs. The proposed system uses several components: (1) heterogeneous image collection; (2) image pre-processing; (3) ensemble networks; (4) interpretability analysis; and (5) user-interaction module. The extensive experiments are conducted utilizing two different datasets, such as Kvasir and TCIA CT (TCGA-STAD) scan images. The severity annotation of both datasets was carried out by experienced medical doctors, including endoscopists. Several evaluation metrics, including accuracy, precision, and recall, are measured and benchmarked against other learning networks. The experimental findings demonstrate the enhanced performance of the proposed framework over the existing models by achieving the accuracy, precision, recall, and F1-score values of 0.99, 0.997, 0.99, and 0.99, respectively. Furthermore, different LLM models such as GPT4.0, GPT3.5, LLAMA, and GEMINI are integrated, and their mode of interaction is also analyzed with SHAP measurements. The suggested framework demonstrates its strong potential by enhancing diagnostic performance, achieving high performance with user-interacted clinical treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.